Scientists test if COVID vaccine works for vulnerable patients
NCT ID NCT04780659
Summary
This study checked how well the Pfizer/BioNTech COVID-19 vaccine worked in people with weakened immune systems compared to healthy people. Researchers followed 539 adults, including those with conditions like HIV, organ transplants, and cancer, measuring their antibody levels and tracking side effects after two vaccine doses. The goal was to understand if the vaccine provides adequate protection for medically vulnerable populations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska University Hospital
Stockholm, Huddinge, 14186, Sweden
Conditions
Explore the condition pages connected to this study.